DJIA 16,764.14 291.77 1.77%
NASDAQ 4,775.70 67.93 1.44%
S&P 500 1,986.00 34.64 1.78%
market minute promo

Gilead Sciences (NASDAQ: GILD)

99.08 0.80 (0.81%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $99.11 0.84%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $99.99
Previous Close $98.28
Daily Range $97.66 - $101.30
52-Week Range $85.95 - $123.37
Market Cap $145.4B
P/E Ratio 10.33
Dividend (Yield) $1.72 (1.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 11,381,853
Average Daily Volume 13,577,894
Current FY EPS $11.99




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

3 Biotech Bargains to Buy

With biotech stocks tumbling, one Fool points out three top stocks in the industry to buy for the long-haul.

ContraVir Soars 150% as New HBV Drug is 60x More Active than Gilead's Viread

Health Care Sector Update for 10/05/2015: ATRC,CTRV,GILD,SIEN

Biotech Returns Outstanding Even Given Recent Weakness

Strong Upward Pre-Market Activity For Gilead (GILD)

The Case For A 500-Point Cyclical "Bear" Correction - Risks To 1650 SPX

5 Stocks We Bought Recently

Here are our contributors' latest investments and why they bought them.

7 Quality U.S. Stocks That Can Be Purchased At A Discount Right Now

Gilead Will Rebound In The Fourth Quarter

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

See More GILD News...

GILD's Top Competitors

GILD $99.08 (0.81%)
Current stock: GILD
AMGN $143.51 (0.73%)
Current stock: AMGN
BIIB $286.36 (-1.37%)
Current stock: BIIB
CELG $116.72 (0.24%)
Current stock: CELG